Author

E. Conniff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. C. Hirbe· 2 shared C. A. Pratilas· 2 shared D. A. Largaespada· 2 shared D. K. Wood· 2 shared J. C. Pino· 2 shared K. Pollard· 2 shared S. J. Gosline· 2 shared Y. Lyu· 2 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. C. Hirbe

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors

J. Wang, A. Calizo, L. Zhang, J. C. Pino, Y. Lyu, K. Pollard, X. Zhang, A. T. Larsson, E. Conniff, N. Llosa, D. K. Wood, D. A. Largaespada, S. E. Moody, S. J. Gosline, A. C. Hirbe, C. A. Pratilas

This study shows that combining SHP2 inhibitor TNO155 with CDK4/6 inhibitor enhances anti-tumor activity in MPNST by restoring RB function and overcoming resistance.

bioRxiv · Feb 2, 2023Cancer Biology

Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology

H. Bhatia^, A. T. Larsson^, A. Calizo^, K. Pollard, X. Zhang, E. Conniff, J. F. Tibbitts, S. H. Osum, K. B. Williams, A. L. Crampton, T. Jubenville, D. Schefer, K. Yang, Y. Lyu, J. Bade, , A. C. Hirbe

The paper develops an ex vivo 3D microtissue model of MPNST that captures genomic diversity and predicts in vivo drug response.

bioRxiv · Apr 29, 2022 · PreprintCancer Biology